EA
SYRE icon

Emerald Advisers’s Spyre Therapeutics SYRE Stock Holding History

Emerald Advisers’s Portfolio SYRE Stock Details SYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$8.47M Buy
565,863
+18,036
+3% +$270K 0.31% 100
2025
Q1 		$8.84M Buy
547,827
+1,036
+0.2% +$16.7K 0.4% 87
2024
Q4 		$12.7M Buy
546,791
+254,222
+87% +$5.92M 0.49% 78
2024
Q3 		$8.6M Buy
+292,569
New +$8.6M 0.33% 97